Testicular tumors are the leading cause of death from cancer in men from the age of 25 to 34 years, excluding leukemia and lymphoma. Except for the radiosensitive seminoma, results of treatment for these tumors have been disappointing, and chemotherapy is frequently employed. Combination therapy either simultaneous or sequential, appears to be superior to use of a single agent. Individualization of treatment is important in chemotherapy of disseminated testicular neoplasm, and the many agents that have shown efficacy should be appreciated.
📖 افتح في inklap 🔗 DOI 📮 اطلب بحثاً